Starbucks Corp (SBUX)

Chipotle Mexican Grill announced plans this week to enter the crowded Mexican market, partnering with local firm Alsea—which operates brands like Starbucks, Domino’s, and Burger King—to open restaurants by early 2026.

Let's delve into the developments on the US markets in the middle of the day on Friday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Marjorie Taylor Greene disclosed buying more than 50 stocks in early May. A look at the list and why the congresswoman's past trades have drawn red flags.

Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor confidence when the ride gets bumpy.

Same-store sales are down at the coffee chain's U.S. stores. But a successful turnaround isn't off the menu yet.

There are new opportunities landing in the market for those savvy and patient investors hunting for a value play in their portfolios right now.

The fast-growing coffee chain is better loved by consumers than you-know-what in the business, according to a recent survey.

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

SBUX missed Street estimates in its fiscal second quarter, and that too by a significant margin. Still, Niccol asserted that Starbucks stock remains an attractive long-term holding.

This past week, two lower-cost food and beverage retailers posted earnings, which conveyed the underlying message that consumers are struggling.

Starbucks' turnaround gains traction, but analysts enter wait-and-see mode as margin contraction tied to investments cuts into earnings.

U.S. stock futures rose early Thursday morning, following the robust earnings of two "Mag 7" companies after markets closed on Wednesday.

Fast-food chain Wendy’s (NASDAQ:WEN) will be announcing earnings results tomorrow before the bell. Here’s what to expect.

Goldman Sachs lowers its price target to $85 from $103, with several other analysts making similar downward revisions.